NIPH Clinical Trials Search

UMIN ID: UMIN000001358

Registered date:08/09/2008

A Phase II Study of carboplatin plus paclitaxel for advanced thymic cancer

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedThymic cancer
Date of first enrollment2008/05/01
Target sample size40
Countries of recruitmentJapan
Study typeInterventional


Primary OutcomeObjective response rate (RECIST criteria)
Secondary OutcomeOverall survival, Progression survival, Safety

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1)Presence of pleural or pericardial effusion that cannot be controlled by a procedure. 2)Presence of brain tumor with clinical symptoms. 3)Superior vena cava syndrome. 4)Interstitial pneumonitis. 5)Presence of other active malignancy. 6)Acute intercurrent infection or complications 7)History of serious allergy to medical drugs. 8)Uncontrolled psychiatric disease. 9)pregnancy or lactating patients 10)Myasthenia gravis

Related Information


public contact
Name Shinichiro Nakamura
Address Namba Plaza Bldg.3F 1-5-7,Motomachi Naniwa-ku,Osaka556-0016 JAPAN Japan
Telephone 06-6633-7400
Affiliation West Japan Oncology Group WJOG datacenter
scientific contact
Name Takashi Seto
Address Notame 3-1-1, Minami-ku, Fukuoka, 811-1395, Japan Japan
Telephone 092-541-3231
Affiliation National Kyushu Cancer Center Department of Thoracic Oncology